ABOUT
Our Members
Board of Directors
Staff
Our Support
Contact Us
Issue Areas
COVID-19
Health Equity, Diversity, & Inclusion
Reducing Health Costs
Health Care Reform
Value
Real-World Evidence
Patient Engagement
FDA Regulations
Medicaid Unwinding Resources
Resources
Member Resources
Fair-Market Value Calculator
Patient Experience Mapping
A Blueprint for Developing Patient-Centered Core Impact Sets (PC-CIS)
Meetings & Events
Newsroom
Letters & Comments
Research Briefs
Job Bank
Education
Real-World Evidence Classroom
Value Classroom
Patient-Focused Medical Product Development Series
Clinical Outcome Assessment Series
Health Literacy Series
Health Care Quality
Webinars
Blog
Membership
Our Members
Standards of Excellence
CAE Approved Provider
Join Us
Accessibility Tools
Toggle navigation
letters & comments
NHC Comments on Hospital Inpatient Prospective Payment Systems
06/17/2022
Read More
NHC Comments on FDA Diversity in Clinical Trials Guidance
06/13/2022
Read More
Request for Information (RFI): Challenges and Opportunities in Health and Science Communication Research
05/31/2022
Read More
NHC Comments to the FTC on PBM Business Practices and the Impact on Independent Pharmacies and Consumers
05/26/2022
Read More
NHC MDUFA V Public Meeting Comments
04/21/2022
Read More
National Health Council’s (NHC’s) responses to the CMS Request for Information on Access to Care and Coverage for People Enrolled in Medicaid and CHIP
04/18/2022
Read More
NHC Comment Letter on the Potential Expiration of the Public Health Emergency
03/18/2022
Read More
Examining Charitable Giving and Trends in the Nonprofit Sector
03/17/2022
Read More
Statement for the Record: FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics
02/03/2022
Read More
« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next »
